Press Releases
March 27, 2025
Spyre Therapeutics Announces First Participant Dosed in Phase 1 Trial of SPY003, its Novel Half-life Extended IL-23 Antibody
Preclinical data demonstrates that SPY003 is highly potent and has potential for
The Bradford Era
Lifestyles
December 7, 2025
DEAR ABBY: I am a teacher. I love my job, and I love my students. However, as I near the end of my 26th year of teaching, there's something I need to ...
PA State News
December 6, 2025
(TNS) — Ricardo Iriart last saw his wife conscious four years ago. Every day since, he has visited Ángeles, often spending hours talking to her in hop...
PA State News
December 6, 2025
(Editor's note: This article is made possible through Spotlight PA’s collaboration with Votebeat, a nonpartisan news organization covering local elect...
Lifestyles
December 6, 2025
Dear Heloise: I'm a longtime reader of your column in the Daily Breeze, in Torrance, California, and I have a hint that I'd like to pass along: I have...
Lifestyles
December 6, 2025
DEAR ABBY: I'm a man in my 70s. My girlfriend is eight years younger. We were first introduced 42 years ago by relatives who believed we would be a go...
Round the Square
December 6, 2025
ODD: We've all heard sayings like "Not my circus, not my monkeys," but have you ever wondered what they say in other countries? That saying, for examp...
